Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Research Domains

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

Gene A Lang1, Tomoo Iwakuma, Young-Ah Suh

  • 1Department of Molecular Genetics, Section of Cancer Genetics, The University of Texas MD Anderson Cancer Center and The University of Texas Graduate School of Biomedical Sciences, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Cell
|December 21, 2004

Related Experiment Videos

View abstract on PubMed

Summary

Related Concept Videos

  • Biomedical And Clinical Sciences
  • Oncology And Carcinogenesis
  • Predictive And Prognostic Markers
  • Gain Of Function Of A P53 Hot Spot Mutation In A Mouse Model Of Li-fraumeni Syndrome.
  • This summary is machine-generated.

    Li-Fraumeni syndrome patients have inherited mutations in the p53 tumor suppressor gene. Our study shows specific p53 mutations enhance tumor metastasis and cell growth, offering new insights into cancer progression.

    Area of Science:

    • Oncology
    • Genetics
    • Molecular Biology

    Background:

    • Li-Fraumeni syndrome is linked to inherited mutations in the p53 tumor suppressor gene, increasing cancer predisposition.
    • Understanding the functional impact of specific p53 missense mutations is crucial for cancer research.

    Purpose of the Study:

    • To investigate the in vivo mechanistic effects of a common p53 hot spot mutation (p53R175H) on tumor development and progression.
    • To explore the role of p63 and p73 in mediating the gain-of-function phenotypes associated with p53 missense mutations.

    Main Methods:

    • Generation of p53+/515A mice modeling the human p53R175H mutation.
    • Comparative analysis of tumor spectrum, metastasis frequency, and survival in p53+/515A and p53+/- mice.
    • In vitro studies using embryonic fibroblasts from p53515A/515A mice to assess cell proliferation, DNA synthesis, and transformation potential.
    • Functional analysis of p63 and p73 in p53-/- and p53515A/515A cells.

    Main Results:

    • p53+/515A mice exhibited high-frequency tumor metastasis, distinct from p53+/- mice.
    • p53515A/515A embryonic fibroblasts showed increased proliferation, DNA synthesis, and transformation.
    • Disruption of p63 and p73 in p53-/- cells mimicked the enhanced transformation and DNA synthesis observed in p53515A/515A cells.
    • p63 and p73 were functionally inactivated in cells harboring the p53515A mutation.

    Conclusions:

    • Specific p53 missense mutations can confer gain-of-function properties, promoting tumor metastasis and cellular transformation.
    • The findings provide in vivo validation for the oncogenic potential of certain p53 mutations.
    • Functional inactivation of p63 and p73 contributes to the observed phenotypes, suggesting a complex interplay in tumor suppression and progression.

    Related Experiment Videos